BECN1 and obesity disorder: Adipocyte-specific Beclin1 KO mitigated the effects of EGCG on visceral WAT mass, glucose tolerance and energy expenditure, indicating that the anti-obesity effect of EGCG required Beclin1-dependent autophagy (Figure 5B,C).